Announced
Financials
Sources
Tags
supplement commercialization
Italy
Majority
Domestic
Friendly
Single Bidder
Private
Personal Products
Acquisition
Completed
Private Equity
Synopsis
21 Invest, a European investment group, completed the acquisition of Omega Pharma, an Italian player in the R&D and commercialization of food supplements, medical devices and cosmetics. Financial terms were not disclosed. “Building new industrial champions is our main challenge. We found Omega Pharma to be an outstanding entrepreneurial business, focused on technological research and development with high professional standards. We will develop together an ambitious build-up project in the sustainable food supplements sector, as a key starting point for long-term growth," Alessandro Benetton, 21 Invest Chariman and Founder.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.